Robustine

CAS No. 2255-50-7

Robustine( —— )

Catalog No. M24028 CAS No. 2255-50-7

Robustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 267 In Stock
10MG 473 In Stock
25MG 754 In Stock
50MG 1017 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Robustine
  • Note
    Research use only, not for human use.
  • Brief Description
    Robustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.
  • Description
    Robustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE5A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2255-50-7
  • Formula Weight
    215.2
  • Molecular Formula
    C12H9NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (464.68 mM; Need ultrasonic)
  • SMILES
    OC1=C2N=C(OC=C3)C3=C(OC)C2=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Neolignans, a coumarinolignan, lignan derivatives, and a chromene: anti-inflammatory constituents from Zanthoxylum avicennae.J Nat Prod. 2008 Feb;71(2):212-7.
molnova catalog
related products
  • PDE4B-IN-2

    PDE4B-IN-2 (A 33) is an orally active and selective PDE4B inhibitor with an IC50 of 15 nM. PDE4B-IN-2 inhibits PDE4D (IC50=1.7 μM).

  • PF-04957325

    PF-04957325 is a potent and selective inhibitor of PDE8.PF-04957325 has an IC50 of 0.7 nM for PDE8A and 0.3 nM for PDE8B.PF-04957325 can be used to study autoimmune encephalomyelitis.

  • GSK 356278

    A potent, selective, brain-penetrant and orally bioavailable phosphodiesterase 4 (PDE4) inhibitor with pIC50 of 8.8 (PDE4B); equally inhibits PDE4A and PDE4Dwith pIC50 of 8.6 and 8.7.